Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Leo International Precision Health is a biotechnology and healthcare services company dedicated to the field of precision medicine and regenerative science. The company specializes in the research, development, and clinical application of advanced cell therapies, including mesenchymal stem cells (MSCs) and natural killer (NK) cells. Their service portfolio encompasses comprehensive health screenings, precision diagnostics, and personalized health management programs designed to address aging and chronic diseases. Operating primarily in the Asia-Pacific region with headquarters in Hong Kong, the company integrates state-of-the-art laboratory facilities with high-end clinical centers. Leo International aims to enhance human longevity and wellness through the convergence of genomic data and cellular biotechnology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Leo International Precision Health.